Bioorganic & Medicinal Chemistry Letters
Discovery of mobocertinib, a potent, oral inhibitor of <em>EGFR</em> exon 20 insertion mutations in non–small cell lung cancer
Publication date: 15 January 2023Source: Bioorganic & Medicinal Chemistry Letters, Volume 80Author(s): Wei-Sheng Huang, Feng Li, Yongjin Gong, Yun Zhang, Willmen Youngsaye, Yongjin Xu, Xiaotian Zhu, Matthew T. Greenfield, Anna Kohlmann, Paul M. Taslimi…